TCL Archive NCI Staff Will Recommend That Comprehensive Recognition Be Withdrawn From Colorado Center October 31, 1980
TCL Archive The Cancer Letter Provides Full Text Of Publications To University Of Kentucky. October 19, 2001
TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive Strategic Plan Identifies Goal; To Be The Authoritative Source For Cancer Information May 21, 1999
TCL Archive In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs January 17, 1992
